Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia

Acute myeloid leukemia (AML); EZH2; drug resistance; epigenetic; proteasome

Saved in:
Bibliographic Details
Main Authors: Göllner, Stefanie (Author) , Müller-Tidow, Carsten (Author)
Format: Article (Journal)
Language:English
Published: 30 Mar 2017
In: Molecular & cellular oncology
Year: 2017, Volume: 4, Issue: 2, Pages: 1-3
ISSN:2372-3556
DOI:10.1080/23723556.2017.1291396
Online Access:Verlag, Volltext: https://www.tandfonline.com/doi/full/10.1080/23723556.2017.1291396
Resolving-System, Volltext: https://dx.doi.org/10.1080/23723556.2017.1291396
Get full text
Author Notes:Stefanie Göllner and Carsten Müller-Tidow

MARC

LEADER 00000caa a2200000 c 4500
001 1019406259
003 DE-627
005 20230428065406.0
007 cr uuu---uuuuu
008 180424s2017 xx |||||o 00| ||eng c
024 7 |a 10.1080/23723556.2017.1291396  |2 doi 
035 |a (DE-627)1019406259 
035 |a (DE-599)GBV1019406259 
035 |a (OCoLC)1340370535 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Göllner, Stefanie  |d 1979-  |e VerfasserIn  |0 (DE-588)133882764  |0 (DE-627)557870151  |0 (DE-576)300169191  |4 aut 
245 1 0 |a Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia  |c Stefanie Göllner and Carsten Müller-Tidow 
264 1 |c 30 Mar 2017 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Acute myeloid leukemia (AML); EZH2; drug resistance; epigenetic; proteasome 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
773 0 8 |i Enthalten in  |t Molecular & cellular oncology  |d London : Taylor & Francis, 2014  |g 4(2017), 2, Artikel-ID e1291396, Seite 1-3  |h Online-Ressource  |w (DE-627)835890988  |w (DE-600)2835425-4  |w (DE-576)44572093X  |x 2372-3556  |7 nnas  |a Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia 
773 1 8 |g volume:4  |g year:2017  |g number:2  |g elocationid:e1291396  |g pages:1-3  |g extent:3  |a Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia 
856 4 0 |u https://www.tandfonline.com/doi/full/10.1080/23723556.2017.1291396  |x Verlag  |3 Volltext 
856 4 0 |u https://dx.doi.org/10.1080/23723556.2017.1291396  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20200302 
993 |a Article 
994 |a 2017 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 2  |y j 
998 |g 133882764  |a Göllner, Stefanie  |m 133882764:Göllner, Stefanie  |d 910000  |d 910100  |e 910000PG133882764  |e 910100PG133882764  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1019406259  |e 3601534134 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"role":"aut","given":"Stefanie","display":"Göllner, Stefanie","family":"Göllner"},{"given":"Carsten","role":"aut","family":"Müller-Tidow","display":"Müller-Tidow, Carsten"}],"title":[{"title_sort":"Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia","title":"Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia"}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"30 Mar 2017"}],"id":{"eki":["1019406259"],"doi":["10.1080/23723556.2017.1291396"]},"relHost":[{"id":{"issn":["2372-3556"],"zdb":["2835425-4"],"eki":["835890988"]},"recId":"835890988","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemiaMolecular & cellular oncology","note":["Gesehen am 21.09.2024"],"origin":[{"publisher":"Taylor & Francis","dateIssuedKey":"2014","dateIssuedDisp":"2014-","publisherPlace":"London"}],"pubHistory":["1.2014 -"],"title":[{"title":"Molecular & cellular oncology","title_sort":"Molecular & cellular oncology"}],"part":{"pages":"1-3","year":"2017","text":"4(2017), 2, Artikel-ID e1291396, Seite 1-3","issue":"2","extent":"3","volume":"4"},"titleAlt":[{"title":"Molecular and cellular oncology"}],"language":["eng"]}],"recId":"1019406259","physDesc":[{"extent":"3 S."}],"language":["eng"],"name":{"displayForm":["Stefanie Göllner and Carsten Müller-Tidow"]}} 
SRT |a GOELLNERSTINHIBITION3020